Incannex Healthcare Limited
Financial ratios & Valuation

Historical Multiples (2015 – 2024)

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 TTM Median
Valuation Ratios
Price/Earnings ratio
-85.23-424.57-29.85-388.70-872.15-784.89-426.15-111.70-0.57-2.58-9.62-872.15
Price/Sales ratio
N/A3.41K2.19K1.13K1.52M6.09K2.55K2.12KN/A3.97KN/A6.09K
Price/Book Value ratio
494.95-446.70-3.65K-2.98K-5.68K1.16K565.2746.411.354.251.52-5.68K
Price/Cash Flow ratio
-183.79-474.68-230.05-401.92-1.09K-943.64-701.40-129.99-2.63-3.00-44.78-1.09K
Price/Free Cash Flow ratio
-183.25-467.93-225.83-395.32-1.08K-943.64-701.40-129.99-2.55-2.95-9.46-1.08K
Price/Earnings Growth ratio
1.015.34-0.024.2011.40-10.23-3.56129.95-0.000.040.00-10.23
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/A28.37%-83.12%48.22%100%25.54%51.94%99.18%N/A100%N/A25.54%
Operating Profit Margin
N/A-717.70%-935.18%-295.86%-81709.63%-646.61%-538.64%-1450.78%N/A-250341.66%N/A-81709.63%
Pretax Profit Margin
N/A-804.95%-7444.23%-317.24%-91835.00%-649.59%-599.32%-1904.93%N/A-153575%N/A-91835.00%
Net Profit Margin
N/A-804.95%-7336.19%-291.23%-175041.70%-776.61%-599.32%-1904.93%N/A-153825%N/A-175041.70%
Effective Tax Rate
3.99%N/A1.42%8.58%N/AN/AN/AN/AN/A-0.16%N/AN/A
Return on Assets
-44.12%-213.62%-2068.76%-416.46%-524.87%-110.89%-121.91%-39.34%-205.23%-108.28%-15.65%-524.87%
Return On Equity
-580.69%105.21%12254.92%769.07%651.61%-148.45%-132.64%-41.55%-234.38%-164.56%-40.35%-40.35%
Return on Capital Employed
-137.51%93.80%-1153.74%781.29%304.17%-123.60%-119.21%-31.64%-233.91%-262.89%-15.70%-15.70%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A37.63N/A
Quick Ratio
1.080.050.790.280.243.7812.3518.849.012.8837.630.24
Cash ratio
0.030.000.650.200.093.3612.0818.658.671.0436.990.09
Days of Sales Outstanding
N/A22.8110.463.7519.72K135.84N/AN/AN/AN/AN/A135.84
Days of Inventory outstanding
N/A324.07160.12155.08N/A148.44N/AN/AN/AN/AN/A148.44
Operating Cycle
N/A346.88170.59158.84N/A284.29N/AN/AN/AN/AN/A284.29
Days of Payables Outstanding
4.02K790.01378.56344.74N/A478.2693.3074.90KN/AN/A61.56K478.26
Cash Conversion Cycle
N/A-443.12-207.96-185.89N/A-193.97-93.30-74.90KN/AN/AN/AN/A
Debt Ratios
Debt Ratio
0.152.020.390.280.12N/AN/AN/AN/AN/A0.01N/A
Debt Equity Ratio
2.09-0.99-2.35-0.52-0.15N/AN/AN/AN/AN/A0.01-0.15
Long-term Debt to Capitalization
N/AN/A1.73N/AN/AN/AN/AN/AN/AN/A0.00N/A
Total Debt to Capitalization
0.67-472.771.73-1.09-0.18N/AN/AN/AN/AN/A0.00-0.18
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cash Flow to Debt Ratio
-1.28-0.94-6.75-14.25-33.23N/AN/AN/AN/AN/A-13.80-33.23
Company Equity Multiplier
13.16-0.49-5.92-1.84-1.241.331.081.051.141.511.01-1.24
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/A-7.19-9.52-2.81-1.39K-6.45-3.64-16.36N/A-1.32KN/A-1.39K
Free Cash Flow / Operating Cash Flow Ratio
1.001.011.011.011.011111.021.014.721.01
Cash Flow Coverage Ratio
-1.28-0.94-6.75-14.25-33.23N/AN/AN/AN/AN/A-13.80-33.23
Short Term Coverage Ratio
-1.28-0.94N/A-14.25-33.23N/AN/AN/AN/AN/A-63.44N/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A